Michael Handelman
2013 - Lion Biotechnologies
In 2013, Michael Handelman earned a total compensation of $180K as Chief Financial Officer at Lion Biotechnologies, which was the same as previous year.
Compensation breakdown
| Salary | $180,000 |
|---|---|
| Total | $180,000 |
Handelman received $180K in salary, accounting for 100% of the total pay in 2013.
Rankings
In 2013, Michael Handelman's compensation ranked 11,740th out of 12,286 executives tracked by ExecPay. In other words, Handelman earned more than 4.4% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,740 out of 12,286 | 4th |
Division Manufacturing | 4,400 out of 4,612 | 5th |
Major group Chemicals And Allied Products | 1,394 out of 1,462 | 5th |
Industry group Drugs | 1,106 out of 1,156 | 4th |
Industry Biological Products, Except Diagnostic Substances | 186 out of 196 | 5th |
Source: SEC filing on April 30, 2015.
Handelman's colleagues
We found two more compensation records of executives who worked with Michael Handelman at Lion Biotechnologies in 2013.